4540 Stock Overview
Manufactures and sells pharmaceutical products from crude drugs derived from plants and other natural products in Japan and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 5/6 |
| Financial Health | 4/6 |
| Dividends | 4/6 |
Tsumura & Co. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥4,887.00 |
| 52 Week High | JP¥5,138.00 |
| 52 Week Low | JP¥2,580.00 |
| Beta | 0.15 |
| 11 Month Change | 23.72% |
| 3 Month Change | 22.79% |
| 1 Year Change | 86.46% |
| 33 Year Change | 38.05% |
| 5 Year Change | 61.82% |
| Change since IPO | 213.27% |
Recent News & Updates
Tsumura & Co.'s (TSE:4540) Intrinsic Value Is Potentially 47% Above Its Share Price
Oct 17
Tsumura (TSE:4540) Is Increasing Its Dividend To ¥68.00
Sep 26Tsumura & Co.'s (TSE:4540) P/E Still Appears To Be Reasonable
Sep 24Tsumura (TSE:4540) Will Pay A Larger Dividend Than Last Year At ¥68.00
Sep 04Recent updates
Tsumura & Co.'s (TSE:4540) Intrinsic Value Is Potentially 47% Above Its Share Price
Oct 17Tsumura (TSE:4540) Is Increasing Its Dividend To ¥68.00
Sep 26Tsumura & Co.'s (TSE:4540) P/E Still Appears To Be Reasonable
Sep 24Tsumura (TSE:4540) Will Pay A Larger Dividend Than Last Year At ¥68.00
Sep 04Tsumura (TSE:4540) Is Increasing Its Dividend To ¥68.00
Aug 21Tsumura's (TSE:4540) Promising Earnings May Rest On Soft Foundations
Aug 12Tsumura's (TSE:4540) Upcoming Dividend Will Be Larger Than Last Year's
Jul 25Tsumura (TSE:4540) Has Announced That It Will Be Increasing Its Dividend To ¥68.00
Jul 11We Think Tsumura (TSE:4540) Can Stay On Top Of Its Debt
Jun 24News Flash: Analysts Just Made A Sizeable Upgrade To Their Tsumura & Co. (TSE:4540) Forecasts
Mar 28Tsumura (TSE:4540) Will Pay A Dividend Of ¥35.00
Mar 15Earnings Not Telling The Story For Tsumura & Co. (TSE:4540) After Shares Rise 39%
Mar 07Tsumura (TSE:4540) Has Announced A Dividend Of ¥35.00
Feb 26Shareholder Returns
| 4540 | JP Pharmaceuticals | JP Market | |
|---|---|---|---|
| 7D | -0.8% | 0.05% | -0.7% |
| 1Y | 86.5% | 18.0% | 17.4% |
Return vs Industry: 4540 exceeded the JP Pharmaceuticals industry which returned 18% over the past year.
Return vs Market: 4540 exceeded the JP Market which returned 17.4% over the past year.
Price Volatility
| 4540 volatility | |
|---|---|
| 4540 Average Weekly Movement | 5.6% |
| Pharmaceuticals Industry Average Movement | 5.6% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in JP Market | 10.3% |
| 10% least volatile stocks in JP Market | 3.5% |
Stable Share Price: 4540 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 4540's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1893 | 4,138 | Terukazu Kato | www.tsumura.co.jp |
Tsumura & Co. manufactures and sells pharmaceutical products from crude drugs derived from plants and other natural products in Japan and internationally. The company offers Kampo extract intermediates, granular and prescription Kampo formulations, over-the-counter Kampo medicine, other medications, and herbal bath salts. It offers its products for female problems, proneness to fatigue, skin problems, gastrointestinal problems, obesity, constipation, hemorrhoid, body aches, cold, cough, nasal/throat inflammation, children's sickness, stress, and urinary problems.
Tsumura & Co. Fundamentals Summary
| 4540 fundamental statistics | |
|---|---|
| Market cap | JP¥371.06b |
| Earnings (TTM) | JP¥23.56b |
| Revenue (TTM) | JP¥157.50b |
15.8x
P/E Ratio2.4x
P/S RatioIs 4540 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4540 income statement (TTM) | |
|---|---|
| Revenue | JP¥157.50b |
| Cost of Revenue | JP¥82.55b |
| Gross Profit | JP¥74.95b |
| Other Expenses | JP¥51.40b |
| Earnings | JP¥23.56b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 07, 2024
| Earnings per share (EPS) | 310.23 |
| Gross Margin | 47.59% |
| Net Profit Margin | 14.96% |
| Debt/Equity Ratio | 25.9% |
How did 4540 perform over the long term?
See historical performance and comparisonDividends
2.8%
Current Dividend Yield27%
Payout RatioDoes 4540 pay a reliable dividends?
See 4540 dividend history and benchmarks| Tsumura dividend dates | |
|---|---|
| Ex Dividend Date | Sep 27 2024 |
| Dividend Pay Date | Dec 05 2024 |
| Days until Ex dividend | 23 days |
| Days until Dividend pay date | 46 days |
Does 4540 pay a reliable dividends?
See 4540 dividend history and benchmarks